About the Authors

Vita W. Jongen

Roles Formal analysis, Visualization, Writing – original draft

vjongen@ggd.amsterdam.nl

Affiliation Department of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands

Maarten F. Schim van der Loeff

Roles Formal analysis, Supervision, Writing – review & editing

Affiliations Department of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands, Amsterdam UMC, Univ of Amsterdam, Internal Medicine, Amsterdam Infection and Immunity (AII), Amsterdam, The Netherlands

Matthys H. Botha

Roles Investigation, Writing – review & editing

Affiliation Department of Obstetrics and Gynaecology, Stellenbosch University, Cape Town, South Africa

Staci L. Sudenga

Roles Conceptualization, Writing – review & editing

Affiliation Division of Epidemiology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

Martha E. Abrahamsen

Roles Data curation, Writing – review & editing

Affiliation Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, Tampa, Florida, United States of America

Anna R. Giuliano

Roles Conceptualization, Writing – review & editing

Affiliation Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, Tampa, Florida, United States of America

Competing Interests

The authors have read the journal’s policy and have the following competing interests: ARG received a grant (IISP39582) from Merck during the course of this study and is a member of Merck research advisory boards. This does not alter our adherence to PLOS ONE policies on sharing data and materials. ARG and SLS received research funding from Merck outside the scope of this study. MFSvdL received research funding from Sanofi-Pasteur MSD; he is a co-investigator in a Sanofi-Pasteur-MSD HPV vaccine trial; he sat on a vaccine advisory board of GSK; his institution received in-kind contribution for an HPV study from Stichting Pathologie Onderzoek en Ontwikkeling (SPOO); his institution receives research funding from Janssen Infectious Diseases and Vaccines. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The other authors declare no conflicts of interest.